506 related articles for article (PubMed ID: 33887242)
1. Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.
Heaney LG; Perez de Llano L; Al-Ahmad M; Backer V; Busby J; Canonica GW; Christoff GC; Cosio BG; FitzGerald JM; Heffler E; Iwanaga T; Jackson DJ; Menzies-Gow AN; Papadopoulos NG; Papaioannou AI; Pfeffer PE; Popov TA; Porsbjerg CM; Rhee CK; Sadatsafavi M; Tohda Y; Wang E; Wechsler ME; Alacqua M; Altraja A; Bjermer L; Björnsdóttir US; Bourdin A; Brusselle GG; Buhl R; Costello RW; Hew M; Koh MS; Lehmann S; Lehtimäki L; Peters M; Taillé C; Taube C; Tran TN; Zangrilli J; Bulathsinhala L; Carter VA; Chaudhry I; Eleangovan N; Hosseini N; Kerkhof M; Murray RB; Price CA; Price DB
Chest; 2021 Sep; 160(3):814-830. PubMed ID: 33887242
[TBL] [Abstract][Full Text] [Related]
2. Asthma Phenotyping in Primary Care: Applying the International Severe Asthma Registry Eosinophil Phenotype Algorithm Across All Asthma Severities.
Kerkhof M; Tran TN; Allehebi R; Canonica GW; Heaney LG; Hew M; Perez de Llano L; Wechsler ME; Bulathsinhala L; Carter VA; Chaudhry I; Eleangovan N; Murray RB; Price CA; Price DB
J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4353-4370. PubMed ID: 34403837
[TBL] [Abstract][Full Text] [Related]
3. Two inflammatory phenotypes of nasal polyps and comorbid asthma.
Wu D; Li L; Zhang M; Wang J; Wei Y
Ann Allergy Asthma Immunol; 2017 Mar; 118(3):318-325. PubMed ID: 28126433
[TBL] [Abstract][Full Text] [Related]
4. Blood eosinophil count group shifts and kinetics in severe eosinophilic asthma.
Lugogo NL; Kreindler JL; Martin UJ; Cook B; Hirsch I; Trudo FJ
Ann Allergy Asthma Immunol; 2020 Aug; 125(2):171-176. PubMed ID: 32334141
[TBL] [Abstract][Full Text] [Related]
5. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes.
Lemière C; Ernst P; Olivenstein R; Yamauchi Y; Govindaraju K; Ludwig MS; Martin JG; Hamid Q
J Allergy Clin Immunol; 2006 Nov; 118(5):1033-9. PubMed ID: 17088126
[TBL] [Abstract][Full Text] [Related]
6. The prevalence and disease burden of severe eosinophilic asthma in Japan.
Nagasaki T; Sato K; Kume N; Oguma T; Sunadome H; Ito I; Izuhara Y; Okamoto K; Kobayashi S; Ohno T; Mizukami A; Kobayashi A; Kaise T; Kuroda T; Mishima M; Matsumoto H
J Asthma; 2019 Nov; 56(11):1147-1158. PubMed ID: 30822174
[No Abstract] [Full Text] [Related]
7. Proportion of Severe Asthma Patients Eligible for Mepolizumab Therapy by Age and Age of Onset of Asthma.
Comberiati P; McCormack K; Malka-Rais J; Spahn JD
J Allergy Clin Immunol Pract; 2019; 7(8):2689-2696.e2. PubMed ID: 31201938
[TBL] [Abstract][Full Text] [Related]
8. Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
Heaney LG; Busby J; Hanratty CE; Djukanovic R; Woodcock A; Walker SM; Hardman TC; Arron JR; Choy DF; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Mansur AH; Fowler SJ; Niven RM; Howarth PH; Lordan JL; Menzies-Gow A; Harrison TW; Robinson DS; Holweg CTJ; Matthews JG; Pavord ID;
Lancet Respir Med; 2021 Jan; 9(1):57-68. PubMed ID: 32916135
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study.
Al-Jahdali H; Wali S; Albanna AS; Allehebi R; Al-Matar H; Fattouh M; Beekman M
BMC Pulm Med; 2022 Feb; 22(1):67. PubMed ID: 35177038
[TBL] [Abstract][Full Text] [Related]
10. The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization.
Viinanen A; Lassenius MI; Toppila I; Karlsson A; Veijalainen L; Idänpään-Heikkilä JJ; Laitinen T
J Asthma; 2020 Oct; 57(10):1092-1102. PubMed ID: 31267775
[No Abstract] [Full Text] [Related]
11. Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
Kulkarni NS; Hollins F; Sutcliffe A; Saunders R; Shah S; Siddiqui S; Gupta S; Haldar P; Green R; Pavord I; Wardlaw A; Brightling CE
J Allergy Clin Immunol; 2010 Jul; 126(1):61-9.e3. PubMed ID: 20639010
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of type 2 disease status in a real-world population of difficult to manage asthma using historic electronic healthcare records of blood eosinophil counts.
Azim A; Newell C; Barber C; Harvey M; Knight D; Freeman A; Fong WCG; Dennison P; Haitchi HM; Djukanovic R; Kurukulaaratchy R; Howarth P
Clin Exp Allergy; 2021 Jun; 51(6):811-820. PubMed ID: 33528864
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic significance of blood eosinophil count in eosinophilic chronic rhinosinusitis with nasal polyps in Chinese adults.
Hu Y; Cao PP; Liang GT; Cui YH; Liu Z
Laryngoscope; 2012 Mar; 122(3):498-503. PubMed ID: 22252861
[TBL] [Abstract][Full Text] [Related]
14. Potential Severe Asthma Hidden in UK Primary Care.
Ryan D; Heatley H; Heaney LG; Jackson DJ; Pfeffer PE; Busby J; Menzies-Gow AN; Jones R; Tran TN; Al-Ahmad M; Backer V; Belhassen M; Bosnic-Anticevich S; Bourdin A; Bulathsinhala L; Carter V; Chaudhry I; Eleangovan N; FitzGerald JM; Gibson PG; Hosseini N; Kaplan A; Murray RB; Rhee CK; Van Ganse E; Price DB
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1612-1623.e9. PubMed ID: 33309935
[TBL] [Abstract][Full Text] [Related]
15. A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED.
Kuo CS; Pavlidis S; Loza M; Baribaud F; Rowe A; Pandis I; Hoda U; Rossios C; Sousa A; Wilson SJ; Howarth P; Dahlen B; Dahlen SE; Chanez P; Shaw D; Krug N; Sandstrӧm T; De Meulder B; Lefaudeux D; Fowler S; Fleming L; Corfield J; Auffray C; Sterk PJ; Djukanovic R; Guo Y; Adcock IM; Chung KF;
Am J Respir Crit Care Med; 2017 Feb; 195(4):443-455. PubMed ID: 27580351
[TBL] [Abstract][Full Text] [Related]
16. Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma.
Kritikos V; Harvey ES; Stevens S; Katelaris CH; Langton D; Rimmer J; Farah CS; Gillman A; Hew M; Radhakrishna N; Thomas D; Gibson PG;
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):885-895.e13. PubMed ID: 36572182
[TBL] [Abstract][Full Text] [Related]
17. Severe adult-onset asthma: A distinct phenotype.
Amelink M; de Groot JC; de Nijs SB; Lutter R; Zwinderman AH; Sterk PJ; ten Brinke A; Bel EH
J Allergy Clin Immunol; 2013 Aug; 132(2):336-41. PubMed ID: 23806634
[TBL] [Abstract][Full Text] [Related]
18. Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma.
Chipps BE; Newbold P; Hirsch I; Trudo F; Goldman M
Ann Allergy Asthma Immunol; 2018 May; 120(5):504-511.e4. PubMed ID: 29409951
[TBL] [Abstract][Full Text] [Related]
19. Race is associated with differences in airway inflammation in patients with asthma.
Nyenhuis SM; Krishnan JA; Berry A; Calhoun WJ; Chinchilli VM; Engle L; Grossman N; Holguin F; Israel E; Kittles RA; Kraft M; Lazarus SC; Lehman EB; Mauger DT; Moy JN; Peters SP; Phipatanakul W; Smith LJ; Sumino K; Szefler SJ; Wechsler ME; Wenzel S; White SR; Ackerman SJ
J Allergy Clin Immunol; 2017 Jul; 140(1):257-265.e11. PubMed ID: 28069248
[TBL] [Abstract][Full Text] [Related]
20. Impact of short-term pausing of oral corticosteroids on blood eosinophil count in patients with severe asthma.
Biener L; Milger K; Suhling H; Korn S; Pizarro C; Skowasch D
Pneumologie; 2023 Jun; 77(6):357-362. PubMed ID: 36384226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
